.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Federal Trade Commission
Deloitte
Teva
Daiichi Sankyo
Novartis
Boehringer Ingelheim
Covington
Chinese Patent Office
Queensland Health

Generated: June 28, 2017

DrugPatentWatch Database Preview

METAHYDRIN Drug Profile

« Back to Dashboard

Which patents cover Metahydrin, and when can generic versions of Metahydrin launch?

Metahydrin is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in METAHYDRIN is trichlormethiazide. There is one drug master file entry for this compound. Additional details are available on the trichlormethiazide profile page.

Summary for Tradename: METAHYDRIN

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list39
Patent Applications: see list2,287
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:METAHYDRIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
METAHYDRIN
trichlormethiazide
TABLET;ORAL012594-001Jun 16, 1988DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
METAHYDRIN
trichlormethiazide
TABLET;ORAL012594-002Jun 16, 1988DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Healthtrust
UBS
Deloitte
Fish and Richardson
Baxter
Fuji
Cantor Fitzgerald
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot